首页> 美国卫生研究院文献>Nucleic Acids Research >AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system
【2h】

AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system

机译:AGO / RISC介导的抗病毒RNA在植物体外系统中的沉默

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AGO/RISC-mediated antiviral RNA silencing, an important component of the plant’s immune response against RNA virus infections, was recapitulated in vitro. Cytoplasmic extracts of tobacco protoplasts were applied that supported Tombusvirus RNA replication, as well as the formation of RNA-induced silencing complexes (RISC) that could be functionally reconstituted with various plant ARGONAUTE (AGO) proteins. For example, when RISC containing AGO1, 2, 3 or 5 were programmed with exogenous siRNAs that specifically targeted the viral RNA, endonucleolytic cleavages occurred and viral replication was inhibited. Antiviral RNA silencing was disabled by the viral silencing suppressor p19 when this was present early during RISC formation. Notably, with replicating viral RNA, only (+)RNA molecules were accessible to RISC, whereas (−)RNA replication intermediates were not. The vulnerability of viral RNAs to RISC activity also depended on the RNA structure of the target sequence. This was most evident when we characterized viral siRNAs (vsiRNAs) that were particularly effective in silencing with AGO1- or AGO2/RISC. These vsiRNAs targeted similar sites, suggesting that accessible parts of the viral (+)RNA may be collectively attacked by different AGO/RISC. The in vitro system was, hence, established as a valuable tool to define and characterize individual molecular determinants of antiviral RNA silencing.
机译:在体外概述了AGO / RISC介导的抗病毒RNA沉默,这是植物抵抗RNA病毒感染的免疫反应的重要组成部分。应用了烟草原生质体的细胞质提取物,以支持Tombusvirus RNA复制,以及形成RNA诱导的沉默复合物(RISC),该复合物可以用各种植物ARGONAUTE(AGO)蛋白功能重建。例如,当将含有AGO1、2、3或5的RISC用专门靶向病毒RNA的外源siRNA进行编程时,会发生内切核酸酶裂解,并抑制了病毒复制。当在RISC形成的早期出现时,病毒沉默抑制剂p19会禁用抗病毒RNA沉默。值得注意的是,通过复制病毒RNA,RISC仅可访问(+)RNA分子,而(-)RNA复制中间体则不可。病毒RNA对RISC活性的脆弱性还取决于靶序列的RNA结构。当我们鉴定病毒siRNA(vsiRNA)对用AGO1-或AGO2 / RISC沉默特别有效时,这一点最为明显。这些vsiRNA靶向相似的位点,表明病毒(+)RNA的可及部分可能受到不同AGO / RISC的共同攻击。因此,建立了体外系统,将其作为定义和表征抗病毒RNA沉默的分子决定因素的有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号